Cost-effectiveness of ADHD treatments: Findings from the multimodal treatment study of children with ADHD

Peter S. Jensen, Joe Albert Garcia, Sharon Glied, Maura Crowe, Mike Foster, Michael Schlander, Stephen Hinshaw, Benedetto Vitiello, L. Eugene Arnold, Glen Elliott, Lily Hechtman, Jeffrey H. Newcorn, William E. Pelham, James Swanson, Karen Wells

Research output: Contribution to journalArticle

Abstract

Objective: Attention deficit hyperactivity disorder (ADHD) is a costly public health problem. To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study). Method: Five hundred seventy-nine children with ADHD, combined type, ages 7 to 9.9, were assigned to 14 months of medication management, behavioral treatment, both combined, or community care. Services were tallied throughout the study, including medication, health care visits, behavioral treatments, and rental costs. Provider specialty, total time, and number of visits with providers were used to calculate costs, adjusted to FY 2000 dollars with the consumer price index. Results: Treatment costs varied fourfold, with medication management being the least expensive, followed by behavioral treatment, and then combined treatment. Lower costs of medication treatment were found in the community care group, reflecting the less intensive (and less effective) nature of community-delivered treatment. Medical management was more effective but more costly than community care and more cost-effective than combination treatment and behavioral treatment alone. Under some conditions, combination treatment (medical management and psychotherapy) were somewhat more cost-effective, as demonstrated by lower costs per additional child "normalized" among children with multiple comorbid disorders. Conclusions: Medical management treatment, although not as effective as combined medical management and behavioral treatment, is likely to be more cost-effective in routine treatment for children with ADHD, particularly those without comorbid disorders. For some children with comorbid disorders, it may be cost-effective to provide combination treatment.

Original languageEnglish (US)
Pages (from-to)1628-1636
Number of pages9
JournalAmerican Journal of Psychiatry
Volume162
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Combined Modality Therapy
Attention Deficit Disorder with Hyperactivity
Cost-Benefit Analysis
Costs and Cost Analysis
Therapeutics
Health Care Costs
Pemetrexed
National Institute of Mental Health (U.S.)
Psychotherapy
Public Health

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cost-effectiveness of ADHD treatments : Findings from the multimodal treatment study of children with ADHD. / Jensen, Peter S.; Garcia, Joe Albert; Glied, Sharon; Crowe, Maura; Foster, Mike; Schlander, Michael; Hinshaw, Stephen; Vitiello, Benedetto; Arnold, L. Eugene; Elliott, Glen; Hechtman, Lily; Newcorn, Jeffrey H.; Pelham, William E.; Swanson, James; Wells, Karen.

In: American Journal of Psychiatry, Vol. 162, No. 9, 09.2005, p. 1628-1636.

Research output: Contribution to journalArticle

Jensen, PS, Garcia, JA, Glied, S, Crowe, M, Foster, M, Schlander, M, Hinshaw, S, Vitiello, B, Arnold, LE, Elliott, G, Hechtman, L, Newcorn, JH, Pelham, WE, Swanson, J & Wells, K 2005, 'Cost-effectiveness of ADHD treatments: Findings from the multimodal treatment study of children with ADHD', American Journal of Psychiatry, vol. 162, no. 9, pp. 1628-1636. https://doi.org/10.1176/appi.ajp.162.9.1628
Jensen, Peter S. ; Garcia, Joe Albert ; Glied, Sharon ; Crowe, Maura ; Foster, Mike ; Schlander, Michael ; Hinshaw, Stephen ; Vitiello, Benedetto ; Arnold, L. Eugene ; Elliott, Glen ; Hechtman, Lily ; Newcorn, Jeffrey H. ; Pelham, William E. ; Swanson, James ; Wells, Karen. / Cost-effectiveness of ADHD treatments : Findings from the multimodal treatment study of children with ADHD. In: American Journal of Psychiatry. 2005 ; Vol. 162, No. 9. pp. 1628-1636.
@article{1475dcdaade547d8a0ba36618d33f129,
title = "Cost-effectiveness of ADHD treatments: Findings from the multimodal treatment study of children with ADHD",
abstract = "Objective: Attention deficit hyperactivity disorder (ADHD) is a costly public health problem. To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study). Method: Five hundred seventy-nine children with ADHD, combined type, ages 7 to 9.9, were assigned to 14 months of medication management, behavioral treatment, both combined, or community care. Services were tallied throughout the study, including medication, health care visits, behavioral treatments, and rental costs. Provider specialty, total time, and number of visits with providers were used to calculate costs, adjusted to FY 2000 dollars with the consumer price index. Results: Treatment costs varied fourfold, with medication management being the least expensive, followed by behavioral treatment, and then combined treatment. Lower costs of medication treatment were found in the community care group, reflecting the less intensive (and less effective) nature of community-delivered treatment. Medical management was more effective but more costly than community care and more cost-effective than combination treatment and behavioral treatment alone. Under some conditions, combination treatment (medical management and psychotherapy) were somewhat more cost-effective, as demonstrated by lower costs per additional child {"}normalized{"} among children with multiple comorbid disorders. Conclusions: Medical management treatment, although not as effective as combined medical management and behavioral treatment, is likely to be more cost-effective in routine treatment for children with ADHD, particularly those without comorbid disorders. For some children with comorbid disorders, it may be cost-effective to provide combination treatment.",
author = "Jensen, {Peter S.} and Garcia, {Joe Albert} and Sharon Glied and Maura Crowe and Mike Foster and Michael Schlander and Stephen Hinshaw and Benedetto Vitiello and Arnold, {L. Eugene} and Glen Elliott and Lily Hechtman and Newcorn, {Jeffrey H.} and Pelham, {William E.} and James Swanson and Karen Wells",
year = "2005",
month = "9",
doi = "10.1176/appi.ajp.162.9.1628",
language = "English (US)",
volume = "162",
pages = "1628--1636",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "9",

}

TY - JOUR

T1 - Cost-effectiveness of ADHD treatments

T2 - Findings from the multimodal treatment study of children with ADHD

AU - Jensen, Peter S.

AU - Garcia, Joe Albert

AU - Glied, Sharon

AU - Crowe, Maura

AU - Foster, Mike

AU - Schlander, Michael

AU - Hinshaw, Stephen

AU - Vitiello, Benedetto

AU - Arnold, L. Eugene

AU - Elliott, Glen

AU - Hechtman, Lily

AU - Newcorn, Jeffrey H.

AU - Pelham, William E.

AU - Swanson, James

AU - Wells, Karen

PY - 2005/9

Y1 - 2005/9

N2 - Objective: Attention deficit hyperactivity disorder (ADHD) is a costly public health problem. To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study). Method: Five hundred seventy-nine children with ADHD, combined type, ages 7 to 9.9, were assigned to 14 months of medication management, behavioral treatment, both combined, or community care. Services were tallied throughout the study, including medication, health care visits, behavioral treatments, and rental costs. Provider specialty, total time, and number of visits with providers were used to calculate costs, adjusted to FY 2000 dollars with the consumer price index. Results: Treatment costs varied fourfold, with medication management being the least expensive, followed by behavioral treatment, and then combined treatment. Lower costs of medication treatment were found in the community care group, reflecting the less intensive (and less effective) nature of community-delivered treatment. Medical management was more effective but more costly than community care and more cost-effective than combination treatment and behavioral treatment alone. Under some conditions, combination treatment (medical management and psychotherapy) were somewhat more cost-effective, as demonstrated by lower costs per additional child "normalized" among children with multiple comorbid disorders. Conclusions: Medical management treatment, although not as effective as combined medical management and behavioral treatment, is likely to be more cost-effective in routine treatment for children with ADHD, particularly those without comorbid disorders. For some children with comorbid disorders, it may be cost-effective to provide combination treatment.

AB - Objective: Attention deficit hyperactivity disorder (ADHD) is a costly public health problem. To the authors' knowledge, this is the first study on the cost-effectiveness of the major forms of ADHD treatments used in NIMH's Multimodal Treatment Study of Children With ADHD (MTA Study). Method: Five hundred seventy-nine children with ADHD, combined type, ages 7 to 9.9, were assigned to 14 months of medication management, behavioral treatment, both combined, or community care. Services were tallied throughout the study, including medication, health care visits, behavioral treatments, and rental costs. Provider specialty, total time, and number of visits with providers were used to calculate costs, adjusted to FY 2000 dollars with the consumer price index. Results: Treatment costs varied fourfold, with medication management being the least expensive, followed by behavioral treatment, and then combined treatment. Lower costs of medication treatment were found in the community care group, reflecting the less intensive (and less effective) nature of community-delivered treatment. Medical management was more effective but more costly than community care and more cost-effective than combination treatment and behavioral treatment alone. Under some conditions, combination treatment (medical management and psychotherapy) were somewhat more cost-effective, as demonstrated by lower costs per additional child "normalized" among children with multiple comorbid disorders. Conclusions: Medical management treatment, although not as effective as combined medical management and behavioral treatment, is likely to be more cost-effective in routine treatment for children with ADHD, particularly those without comorbid disorders. For some children with comorbid disorders, it may be cost-effective to provide combination treatment.

UR - http://www.scopus.com/inward/record.url?scp=24944543923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944543923&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.162.9.1628

DO - 10.1176/appi.ajp.162.9.1628

M3 - Article

VL - 162

SP - 1628

EP - 1636

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 9

ER -